Skip to main navigation Skip to search Skip to main content

Randomized Phase II Study of Two Schedules of Flavopiridol (Alvocidib, F) Given as Timed Sequential Therapy (TST) Wtih Ara-C and Mitoxantrone (FLAM) for Adults with Newly Diagnosed, Poor-Risk Acute Myelogenous Leukemia (AML)

  • Judith E. Karp
  • , John M. Pagel
  • , B. Douglas Smith
  • , Jacqueline M Greer
  • , D. Michelle Drye
  • , Kelly M. Smith
  • , Kathleen Dorcy
  • , John J Wright
  • , L. Austin Doyle
  • , Elizabeth Garrett-Mayer
  • , Elihu H. Estey

    Research output: Contribution to journal › Article › peer-review

    Original languageAmerican English
    JournalBlood
    Volume116
    StatePublished - Nov 19 2010

    Disciplines

    • Medicine and Health Sciences
    • Critical Care
    • Immunology and Infectious Disease

    Cite this